Qorvo Biotechnologies Awarded $4.1 Million National Institutes of Health Contract for SARS-CoV-2/ Flu Combo and Antigen Pooling
Source:
Nasdaq GlobeNewswire
/
07 Feb 2022 07:00:00 America/Chicago
N/A
Share on,